Across TCGA pan-cancer cohorts, LRRC37A11P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LRRC37A11P data layer compared with 25 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher LRRC37A11P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LRRC37A11P expression acts as an unfavorable survival marker.

LUSC are the cancer types where LRRC37A11P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.170	0.675	.025	15	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: LRRC37A11P tumor-vs-normal RNA expression · all LRRC37A11P data types